Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Jean Louis Montastruc »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jean Louis Golmard < Jean Louis Montastruc < Jean Luc Houeto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000222 (2010) Laurence Nègre-Pagès [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lépine [France] ; Olivier Rascol [France]Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study
000228 (2010) Laurence Negre-Pages [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lepine [France] ; Olivier Rascol [France]Anxious and Depressive Symptoms in Parkinson's Disease: The French Cross-Sectionnal DoPAMiP Study
000391 (2005) Agnès Sommet [France] ; Cécile Azaïs-Vuillemin [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Jean Louis Montastruc [France]Trimetazidine: A new cause for drug‐induced parkinsonism?
000407 (2005) Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; François Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France]Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
000421 (2005) Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; Francois Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France]Effect of levodopa on pain threshold in Parkinson's disease : A clinical and positron emission tomography study
000535 (1999) Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
000564 (1998) Nelly Fabre [France] ; Christine Brefel [France] ; Umberto Sabatini [Italie] ; Pierre Celsis [France] ; Jean Louis Montastruc [France] ; François Chollet [France] ; Rascol [France]Normal frontal perfusion in patients with frozen gait
000569 (1998) Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Humans
5Aged
4Female
4Parkinson disease
4Parkinson's disease
3Adult
3Aged, 80 and over
3Male
3Middle Aged
3Parkinson Disease (drug therapy)
3Parkinson Disease (physiopathology)
2Brain Mapping
2Dose-Response Relationship, Drug
2Emission tomography
2Levodopa (therapeutic use)
2Nervous system diseases
2Progressive supranuclear palsy
2Prospective Studies
2Supranuclear Palsy, Progressive (physiopathology)
1Adrenergic alpha-Antagonists (adverse effects)
1Adrenergic alpha-Antagonists (therapeutic use)
1Age Factors
1Agonist
1Agonists
1Alpha‐2 antagonist
1Anti-Anxiety Agents (therapeutic use)
1Antidepressive Agents (therapeutic use)
1Antiparkinson Agents (therapeutic use)
1Antiparkinson agent
1Anxiety
1Anxiety (drug therapy)
1Anxiety (epidemiology)
1Anxiety (etiology)
1Anxiety (physiopathology)
1Benzofurans (adverse effects)
1Benzofurans (therapeutic use)
1Benzothiazoles
1Blocking
1Blood Flow Velocity (physiology)
1Body movement
1Bromocriptine
1Bromocriptine (pharmacology)
1Bromocriptine (therapeutic use)
1Cabergoline
1Case-Control Studies
1Cerebral Cortex (blood supply)
1Cerebrovascular Circulation (drug effects)
1Chemotherapy
1Clinical trial
1Comparative study
1Cross-Over Studies
1Cross-Sectional Studies
1Depression
1Depression (drug therapy)
1Depression (epidemiology)
1Depression (etiology)
1Depression (physiopathology)
1Dominance, Cerebral (physiology)
1Dopamine
1Dopamine Agonists (pharmacology)
1Dopamine Agonists (therapeutic use)
1Dopamine receptor
1Double-Blind Method
1Drug Administration Schedule
1Drug Therapy, Combination
1Early
1Early treatment of Parkinson's disease
1Efaroxan
1Ergolines (pharmacology)
1Ergolines (therapeutic use)
1Exploration
1France (epidemiology)
1Freezing
1French
1Frontal Lobe (blood supply)
1Frontal Lobe (radionuclide imaging)
1Frontal lobe
1Gait (physiology)
1Gait disorder
1H215O positron emission tomography
1Hemodynamics
1Human
1Hypertension (drug therapy)
1Idiopathic
1Imidazoles (adverse effects)
1Imidazoles (therapeutic use)
1Indoles (pharmacology)
1Indoles (therapeutic use)
1Isolated gait ignition failure
1Levodopa
1Lisuride
1Lisuride (pharmacology)
1Lisuride (therapeutic use)
1Logistic Models
1Mental Status Schedule
1Muscle Rigidity (physiopathology)
1Muscle Rigidity (radionuclide imaging)
1Neurologic Examination
1Neurologic Examination (drug effects)
1Neurons (physiology)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Jean Louis Montastruc" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Jean Louis Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Jean Louis Montastruc
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024